Skip to content
PILLARS
Home
Bills
Recent BillsThe latest bills in Congress, in plain EnglishTrending BillsThe PILLARS Top 10 this week
Politicians
PoliticiansCongress, the White House and your repsPresidential ActionsOrders, memos and proclamationsExecutive BranchThe President, Vice President and Cabinet
Elections
Actions
More
Our SourcesWhere every number comes fromApp DetailsOur mission and the team behind itFeedbackTell us what is wrong or missingDownload the AppPILLARS for iPhone and Android
HomeRecent BillsActionsMore
ExploreElectionsPresidential ActionsPoliticiansTrending Bills
WatchlistSettingsProfile
HomeRecent BillsActionsMore
PILLARS

The bills, politicians, and elections that shape your life, in plain English.

Get the App
Our Receipts
Sources & MethodologyApp DetailsSend Feedback
The Legal Stuff
Privacy PolicyTerms of ServiceContact Us
Find Us On
© 2026 Political Pillars Inc.Simplifying politics
Simplifies Approval for Biosimilar Drugs
Recent Bills/Simplifies Approval for Biosimilar Drugs

Simplifies Approval for Biosimilar Drugs

IntroducedApril 10, 2025
In the Senate3 months ago
Intro
Senate
House
Pres
Ready for a Senate vote.
No date is set.
Why This Matters

This bill changes the approval process for biosimilar drugs by removing the requirement for certain clinical studies, making it easier for these drugs to reach the market.

If you use biosimilar medications, this bill could help bring more options to the market faster.
Who this affects
Patients using biosimilars · Pharmaceutical companies
What this bill changes
  1. 1The bill allows biosimilar drugs to be approved without requiring studies on immunogenicity or comparative clinical efficacy.
  2. 2The Secretary of Health can still request studies on these factors but must provide a written justification.

How would you vote?

Go deeper

Read the detailed summary

Read full document

Last changed 2 months ago · checked hourly

Bill Progress2 of 4
A bill has to pass the House and Senate, then go to the President.
Intro
Senate
House
Pres
IntroducedApr 10, 2025
Sponsors
See all 3 sponsors
SenateCurrent

Ready for a Senate vote.

No date is set.

House
President

The President

Donald Trump
President
Not Sent Yet
Related Bills
Similar bill
Senate Bill · S 1954
1 of 4 · Introduced
Eases Approval for Biosimilar Drugs
Biosimilar Red Tape Elimination Act
Healthcare
Similar bill
House Bill · HR 5526
1 of 4 · Introduced
Biosimilar Red Tape Elimination Act
Similar bill
Senate Bill · S 832
1 of 4 · Introduced
Extends Drug Price Negotiation Period
EPIC Act of 2025
Healthcare